Skip to main content

Day: March 7, 2024

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Launched VOQUEZNA® (vonoprazan) tablets in November 2023 for the treatment of Erosive GERD (gastroesophageal reflux disease), achieving net revenues of $0.7 million for the fourth quarterEarly physician prescribing demonstrates strong demand for VOQUEZNASecured expanded commercial coverage for VOQUEZNA with a top U.S. pharmacy benefit manager (PBM), growing commercial access to approximately 60 million covered livesStrengthened financial position with access up to an additional $160 million under expanded term loan facility; expected cash runway extended through 2026Management to host conference call today, March 7, 2024, at 8:30 a.m. ETFLORHAM PARK, N.J., March 07, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments...

Continue reading

Aeries Technology to Attend the 36th Annual ROTH Conference

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (“Aeries” or “the Company”) (Nasdaq: AERT), a global professional services and consulting partner, announced today that Daniel Webb, Chief Investment Officer is scheduled to attend the 36th Annual ROTH Conference to be held at the Ritz Carlton in Laguna Niguel, California, on March 17-19, 2024. To submit your ROTH Conference registration request, click here. To schedule a one-on-one meeting with Aeries Technology, please contact your ROTH representative. About Aeries TechnologyAeries Technology (Nasdaq: AERT) is a global professional services and consulting partner for businesses in transformation mode and their stakeholders, including private equity sponsors and their portfolio companies, with customized engagement models that are designed to provide the right...

Continue reading

Cellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud Security

Collaboration with Coalfire Will Deliver Federal Customers Access to Cellebrite SaaS Technology TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 07, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in Digital Investigative solutions for the public and private sectors, today announced the launch of the process to authorize its software-as-a-service offerings with the Federal Risk and Authorization Management Program (FedRAMP®). The authorization will enable Cellebrite’s federal customers to leverage their use of the Company’s SaaS solutions, support faster and more cost-effective procurement processes, eliminate duplicative assessment efforts and ensure consistent application of information security standards. FedRAMP authorization ensures a standardized approach to security assessment, authorization and...

Continue reading

Digital Ally Announces Notable Contract with The Parking Spot

Large Order was Purchased as part of the Company’s Subscription Purchasing Program and Puts its Video Solutions in Near-Airport Locations Across the Country Lenexa, KS, March 07, 2024 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), which develops, manufactures, and markets advanced video recording products and other critical safety products for law enforcement, emergency management, fleet safety and event security, today announced a notable order for 405 EVO Fleets by The Parking Spot, the leading near-airport parking company in the United States with 47 locations at 28 major U.S. airports. This order reflects the growing demand for Digital Ally’s Commercial Fleet ecosystem, which also includes the FirstVu Pro body camera and FleetVu™ Manager cloud storage and software platform. “We have been a client...

Continue reading

Teladoc Health Expands Obesity & Weight Management Capabilities

Personalized health and medical care program built to improve weight related care and reduce the chronic disease complications of obesity in a single integrated experience PURCHASE, NY, March 07, 2024 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today announced expanded capabilities designed to help employers and health plans manage rising demand for anti-obesity medication such as glucagon-like peptide 1 (GLP-1) agonists and support safe, sustainable weight loss and cardiometabolic health improvement for members. New features include helping plan sponsors and pharmacy benefit managers manage and optimize the growing complexity and costs associated with obesity management, as well as care coordination with non-Teladoc Health physicians and lab testing. The multidisciplinary...

Continue reading

Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

BOSTON and ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases, today announced that Dr. Milton Werner, President and Chief Executive Officer of Inhibikase Therapeutics, will present an update on the of the 201 Trial evaluating risvodetinib (“risvo”) at the 2024 AD/PD Meeting being held March 5-9, 2024 in Lisbon, Portugal. Dr. Werner’s presentation entitled “The 201 Trial in Untreated Parkinson’s Disease” will be presented at the Symposium on “Advances in Parkinson’s Disease and Dementia with Lewy Body Drug Development” to be held on Saturday,...

Continue reading

Zoomcar to Participate in the 36th Annual ROTH Conference

BANGALORE, India, March 07, 2024 (GLOBE NEWSWIRE) — Zoomcar Holdings, Inc. (Nasdaq: ZCAR) (“Zoomcar,” the “Company,” “we,” or “our”), the leading marketplace for car sharing in emerging markets, will be attending the 36th Annual ROTH Conference being held on March 17-19, 2024, at The Ritz Carlton Laguna Niguel in Dana Point California. Zoomcar CEO and Co-Founder Greg Moran will hold one-on-one meetings with institutional investors at the conference. The 36th Annual ROTH Conference will feature one-on-one and small group meetings, company presentations, analyst-selected fireside chats, and industry panels with approximately 500 private and public companies across a variety of growth sectors including Consumer, Technology & Media, Sustainability & Industrial Growth, AgTech, Energy, Metals & Mining, Healthcare, Services,...

Continue reading

Bridgeline Announces Zeus Launch with Concept and Image Search

WOBURN, Mass., March 07, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, announced the release date of its HawkSearch “Smart Search” technology, set for March 15, 2024. Smart Search introduces two new ways to search, Concept and Visual Search, changing how customers interact with search and leading to increased engagement and revenue for businesses. HawkSearch will introduce its “Zeus” update for Smart Search and GenAI capabilities on March 15, 2024. This update introduces AI-powered Concept and Visual Search to help HawkSearch customers generate more revenue. Smart Search uses AI models, vector databases, and large language models to process customer queries, whether typed or through images. For instance, Visual Search allows a customer to upload an image of a product,...

Continue reading

TOMI Expands SteraMist iHP Corporate Service Contracts and Clients

Company announces new partners including The University of Texas and Rising PharmaceuticalsFREDERICK, Md., March 07, 2024 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced an expansion in its SteraMist iHP Corporate Service contracts, reaffirming its position as a leading provider of decontamination services to corporate clients in the life sciences industry. SteraMist iHP technology is becoming the standard decontamination technology in the life sciences sector and academic institutions with a broad spectrum of clients equipped with mobile systems, custom integrations, and service contracts. Through the expansion of corporate services contracts in the life sciences sector, TOMI’s SteraMist iHP technology...

Continue reading

Skyward Specialty Recognizes Key Business Leaders in Wake of Continued Top-Tier Performance

HOUSTON, March 07, 2024 (GLOBE NEWSWIRE) — Skyward Specialty Insurance Group, Inc.TM (NASDAQ: SKWD) (“Skyward Specialty” or “the Company”), a leader in the specialty property and casualty (P&C) market, recognized six of its business leaders with elevated titles to fully reflect their contributions. Each of these six leaders oversee units that have delivered impressive returns on capital and growth, with each now at a size and scale that substantially contributes to the Company’s earnings. The following leaders are now President of their respective areas: Mark Boland of Transactional E&S, Rick Childs of Construction, Doug Davies of Global Property, Jim Mormile of Professional Liability, and Matthew Semeraro of Surety. Additionally, Rob Roberts has been named President of Energy following the transition...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.